சசூன் ஜநரல் மருத்துவமனை புனே News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சசூன் ஜநரல் மருத்துவமனை புனே. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சசூன் ஜநரல் மருத்துவமனை புனே Today - Breaking & Trending Today

Maharashtra: Pune Hospital's Resident Doctors On Strike Over Medical Staff Shortage

Pune district is among the most affected districts in Maharashtra for COVID-19. (Representational)
Pune:
Resident doctors of Pune s Sassoon General Hospital went on strike today over shortage of manpower at the hospital to treat the growing number of patients.
The emergency services will continue during the protest.
Maharashtra Association of Resident Doctors had written a letter to the hospital administration demanding an increase in the number of health staff to treat patients. The administration however did not respond to any of the demands raised by doctors after which the association has decided to stop non-essential and non-emergency-related services.
The hospital administration has not yet reacted to the situation. ....

Vijay Yadav , Maharashtra Association Of Resident Doctors , Pune Hospital , Sassoon General Hospital , Resident Doctors , Sassoon Hospital , Staff Shortage , Sassoon General Hospital Pune , விஜய் யாதவ் , மகாராஷ்டிரா சங்கம் ஆஃப் குடியிருப்பாளர் மருத்துவர்கள் , புனே மருத்துவமனை , சசூன் ஜநரல் மருத்துவமனை , குடியிருப்பாளர் மருத்துவர்கள் , சசூன் மருத்துவமனை , சசூன் ஜநரல் மருத்துவமனை புனே ,

Kochi-based pharma firm's new drug shows 'promising' results against COVID-19

Kochi-based pharma firm s new drug shows promising results against COVID-19
The trial was conducted on 40 patients since November at BJ Government Medical College and Sassoon General Hospital Pune and Victoria Medical College and Research Institute, Bangalore
PB Jayakumar | February 22, 2021 | Updated 15:08 IST
GPP-Baladol, a novel chemical entity (NCE) being developed by pharmaceutical research firm PNB Vesper Life Science for treating Covid-19 patients, claims to have shown promising results in the Phase 2b clinical trials. The pharma firm will soon seek Indian drug regulators approval for emergency use in the country.
The trial was conducted on 40 patients since November at BJ Government Medical College and Sassoon General Hospital Pune and Victoria Medical College and Research Institute, Bangalore. The clinical trial report will be submitted to the DCGI today seeking for an Emergency Use Authorisation to treat hospitalised patients in the country in a ....

United Kingdom , Eric Lattman , Research Institute , Bj Government Medical College , Victoria Medical College , Vesper Life Sciences , Life Science , Medical College , Sassoon General Hospital Pune , Emergency Use Authorisation , Drug Controller General , Vice President , Mask Monitoring , Pnb Wesper Nce For Covid 19 Treatment , Pn Balaram , Ceo Of Pnb Vesper Life Sciences , Victoria Medical College And Research Institute Bangalore , Drug Controller General Of India , ஒன்றுபட்டது கிஂக்டம் , ஆராய்ச்சி நிறுவனம் , பி.ஜே. அரசு மருத்துவ கல்லூரி , விக்டோரியா மருத்துவ கல்லூரி , வெஸ்பர் வாழ்க்கை அறிவியல் , வாழ்க்கை அறிவியல் , மருத்துவ கல்லூரி , சசூன் ஜநரல் மருத்துவமனை புனே ,

PNB Vesper provides potential option to save hospitalised COVID-19 patients globally

PNB Vesper provides potential option to save hospitalised COVID-19 patients globally
PNB Vesper provides potential option to save hospitalised COVID-19 patients globally
12 February 2021 | News
Source credit: Shutterstock
PNB Vesper, a leading Kerala based life sciences company, has announced that it has successfully completed the phase 2 clinical trials of its proprietary drug PNB-001 (GPP-Baladol) on COVID-19 patients. The company had received approval from the Drug Controller General of India (DCGI) to conduct the Phase 2 Clinical trial of GPP-BALADOL in COVID-19 moderate patients with oxygen support in September 2020.
The clinical trial was initiated in November 2020 at BJ Government Medical College and Sassoon General Hospital Pune, and Victoria Medical College and Research Institute, Bengaluru. The clinical trial report will now be submitted to DCGI on February 22, 2021. ....

Eric Lattman , Research Institute , Bj Government Medical College , Victoria Medical College , Vesper Life Sciences , Vesper Life Sciences Pvt Ltd , Drug Controller General , Medical College , Sassoon General Hospital Pune , Clinical Management Protocol , Family Welfare , Life Sciences Pvt Ltd , Vice President , Life Sciences , Victoria Medical College And Research Institute Bengaluru , Gpp Baladol , Pnb 001 , ஆராய்ச்சி நிறுவனம் , பி.ஜே. அரசு மருத்துவ கல்லூரி , விக்டோரியா மருத்துவ கல்லூரி , வெஸ்பர் வாழ்க்கை அறிவியல் , வெஸ்பர் வாழ்க்கை அறிவியல் பிரைவேட் லிமிடெட் , மருந்து கட்டுப்படுத்தி ஜநரல் , மருத்துவ கல்லூரி , சசூன் ஜநரல் மருத்துவமனை புனே , மருத்துவ மேலாண்மை ப்ரோடொகால் ,